Identification Generic Name (1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL DrugBank Accession Number DB07909 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL (DB07909) ×  Close Weight Average: 381.4648  Monoisotopic: 381.194008357  Chemical Formula C 23 H 27 NO 4 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Uncharacterized protein Not Available Humans U Ig gamma-1 chain C region Not Available Humans U Ig kappa chain C region Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom. Kingdom Organic compounds Super Class Organic acids and derivatives Class Carboxylic acids and derivatives Sub Class Amino acids, peptides, and analogues Direct Parent Gamma amino acids and derivatives Alternative Parents Benzamides  /  Benzoyl derivatives  /  Cyclohexanols  /  Secondary carboxylic acid amides  /  Cyclic alcohols and derivatives  /  Monocarboxylic acids and derivatives  /  Carboxylic acids  /  Organopnictogen compounds  /  Organonitrogen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Carbonyl compounds 
 
 
  show 2 more Substituents Alcohol  /  Aromatic homomonocyclic compound  /  Benzamide  /  Benzenoid  /  Benzoic acid or derivatives  /  Benzoyl  /  Carbonyl group  /  Carboxamide group  /  Carboxylic acid  /  Cyclic alcohol  /  Cyclohexanol  /  Gamma amino acid or derivatives  /  Hydrocarbon derivative  /  Monocarboxylic acid or derivatives  /  Monocyclic benzene moiety  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Secondary alcohol  /  Secondary carboxylic acid amide 
 
 
  show 13 more Molecular Framework Aromatic homomonocyclic compounds External Descriptors monocarboxylic acid, cyclohexanols ( CHEBI:43278 )  Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key OBWILOKKNDYPLX-HBMCJLEFSA-N InChI InChI=1S/C23H27NO4/c25-21-15-19(16-5-2-1-3-6-16)12-13-20(21)17-8-10-18(11-9-17)23(28)24-14-4-7-22(26)27/h1-3,5-6,8-11,19-21,25H,4,7,12-15H2,(H,24,28)(H,26,27)/t19-,20+,21-/m0/s1 IUPAC Name 4-({4-[(1R,2S,4S)-2-hydroxy-4-phenylcyclohexyl]phenyl}formamido)butanoic acid SMILES [H][C@]1(O)C[C@]([H])(CC[C@]1([H])C1=CC=C(C=C1)C(=O)NCCCC(O)=O)C1=CC=CC=C1 References General References Not Available External Links PubChem Compound 444394 PubChem Substance 99444380 ChemSpider 392337 ChEBI 43278 ZINC ZINC000006582201 PDBe Ligand HOP PDB Entries 1axs  /  1d6v Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.00298 mg/mL ALOGPS logP 3.3 ALOGPS logP 3.28 Chemaxon logS -5.1 ALOGPS pKa (Strongest Acidic) 4.14 Chemaxon pKa (Strongest Basic) -0.72 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 86.63 Å 2 Chemaxon Rotatable Bond Count 7 Chemaxon Refractivity 108 m 3 ·mol -1 Chemaxon Polarizability 43.82 Å 3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9771 Blood Brain Barrier + 0.8735 Caco-2 permeable - 0.6839 P-glycoprotein substrate Non-substrate 0.56 P-glycoprotein inhibitor I Non-inhibitor 0.812 P-glycoprotein inhibitor II Non-inhibitor 0.6265 Renal organic cation transporter Non-inhibitor 0.7699 CYP450 2C9 substrate Non-substrate 0.7849 CYP450 2D6 substrate Non-substrate 0.8287 CYP450 3A4 substrate Substrate 0.5152 CYP450 1A2 substrate Non-inhibitor 0.9343 CYP450 2C9 inhibitor Non-inhibitor 0.9454 CYP450 2D6 inhibitor Non-inhibitor 0.8363 CYP450 2C19 inhibitor Non-inhibitor 0.9179 CYP450 3A4 inhibitor Non-inhibitor 0.8546 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.913 Ames test Non AMES toxic 0.8625 Carcinogenicity Non-carcinogens 0.9325 Biodegradation Not ready biodegradable 0.52 Rat acute toxicity 2.0055 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9611 hERG inhibition (predictor II) Non-inhibitor 0.665    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Uncharacterized protein Kind Protein Organism Humans Pharmacological action Unknown General Function Not Available Specific Function Not Available Gene Name Not Available Uniprot ID Q7Z3Y4 Uniprot Name Uncharacterized protein Molecular Weight 25701.705 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  
 
 
  Details 2.  Ig gamma-1 chain C region Kind Protein Organism Humans Pharmacological action Unknown General Function Immunoglobulin receptor binding Specific Function Not Available Gene Name IGHG1 Uniprot ID P01857 Uniprot Name Ig gamma-1 chain C region Molecular Weight 36105.695 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  
 
 
  Details 3.  Ig kappa chain C region Kind Protein Organism Humans Pharmacological action Unknown General Function Immunoglobulin receptor binding Specific Function Not Available Gene Name IGKC Uniprot ID P01834 Uniprot Name Ig kappa chain C region Molecular Weight 11608.765 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:26 / Updated at June 12, 2020 16:52 